Ontology highlight
ABSTRACT: Background
Treatment strategies for patients with non-small cell lung cancer (NSCLC) depend on various factors including physical condition, complications, tumor histology, and molecular profiling. Even if initial chemotherapy is efficacious, almost all patients develop treatment resistance. Invasive rebiopsy from sites of recurrence might provide insight into resistance mechanisms and aid in the selection of suitable sequential antitumor drugs. However, invasive rebiopsy might be challenging because of limited tissue availability and patient burden. Therefore, this study aimed to assess awareness of invasive rebiopsy among non-small cell lung cancer patients.Methods
This prospective questionnaire survey was performed between June 2015 and March 2016 in patients with advanc
SUBMITTER: Fukui T
PROVIDER: S-EPMC6397897 | biostudies-literature | 2019 Mar
REPOSITORIES: biostudies-literature